Data on the identification of VRK2 as a mediator of PD-1 function.
Data on the identification of VRK2 as a mediator of PD-1 function.
复制标题
DOI：
10.1016/j.dib.2021.107168
复制
发表时间：
2021-08
期刊：
影响因子：
1.2
通讯作者：
Mor A
中科院分区：
文献类型：
--
作者：
Peled M;Adam K;Mor A
Therapeutic programmed cell death protein 1 (PD-1) blockade enhances T cell mediated anti-tumor immunity, but many patients do not respond, and a significant proportion develops inflammatory toxicities. To develop better therapeutics and to understand the signaling pathways downstream of PD-1 we performed phosphoproteomic interrogation of PD-1 to identify key mediators of PD-1 signaling. Hereby, supporting data of the research article “VRK2 inhibition synergizes with PD-1 blockade to improve T cell responses” are presented. In the primary publication, we proposed that VRK2 is a unique therapeutic target and that combination of VRK2 inhibitors with PD-1 blockade may improve cancer immunotherapy. Here, we provide data on the effect of other kinases on PD-1 signaling utilizing shRNA knockdown of the different kinases in Jurkat T cells. In addition, we used VRK2 inhibition by a pharmacologic approach in the MC38 tumor mouse model, to show the combined outcome of anti PD-1 treatment with VRK2 inhibition. These data provide additional targets downstream PD-1 and point toward methods of testing the effect of the inhibition of these targets on tumor progression in vivo.
登录
查看更多内容
影响因子：
5.7
作者：
Zabludoff, Sonya D.;Deng, Chun;White, Anne M.
通讯作者：
White, Anne M.
影响因子：
5.7
作者：
Blasina, Alessandra;Hallin, Jill;Anderes, Kenna
通讯作者：
Anderes, Kenna
影响因子：
4.4
作者：
Peled, Michael;Tocheva, Anna S.;Adam, Kieran;Mor, Adam
通讯作者：
Mor, Adam
影响因子：
5.7
作者：
King, Constance;Diaz, H. Bruce;Marshall, Mark S.
通讯作者：
Marshall, Mark S.